Surrozen, Inc. Common (SRZN)
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Surrozen, Inc. Common (SRZN) is listed on Nasdaq, where it has traded since August 12, 2021.
- Listed On
- Nasdaq
- Listed Since
- August 12, 2021
- Employees
- 44
- Market Cap
- $357M
About Surrozen, Inc. Common
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-8141(for wet AMD, DME), SZN-413( For retinopathies) and SZN-8143 (for wet AMD, DME, UME).
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 67 institutions reported holding SRZN, with 12.3 million shares worth $314.5 million in aggregate. The largest reported holder was Column Group, with 1.9 million shares worth $49.7 million. Of the 5 largest holders listed below, 1 opened a new position in SRZN, 1 added shares, 1 reduced its position and 2 held their positions unchanged during the quarter.
| Institution | Shares | Value | Quarter change |
|---|---|---|---|
| Column Group | 1,916,950 | $50M | Unchanged |
| Tcg Crossover Management | 1,473,101 | $38M | Unchanged |
| Boxer Capital Management | 1,105,683 | $27M | Added 44.29% |
| Millennium Management | 683,079 | $18M | Reduced 6.57% |
| Point72 Asset Management | 664,272 | $17M | New position |
Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.
Frequently asked questions
What is SRZN?
Surrozen, Inc. Common (SRZN) is listed on Nasdaq, where it has traded since August 12, 2021.
Who are the largest institutional holders of SRZN?
In 13F filings for the quarter ended June 30, 2026, the largest reported holders of SRZN were Column Group, Tcg Crossover Management and Boxer Capital Management.
How many institutions own SRZN?
67 institutions reported a position in SRZN for the quarter ended June 30, 2026, worth $314.5 million in total.
Did institutions buy or sell SRZN last quarter?
Of the 5 largest reported holders, 1 opened a new position in SRZN, 1 added shares, 1 reduced its position and 2 held their positions unchanged during the quarter. Every reported holder and its change is on the SentiSense ownership page for SRZN.
Every reported institutional holder, plus insider and congressional trades in SRZN, on SentiSense.